节点文献

成纤维细胞生长因子21与2型糖尿病关系的研究进展

Research Progress in Relationship between Fibroblast Growth Factor 21 and Type 2 Diabetes

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 万杰君聂本遂滕雅萍郑信华李丽池莲祥

【Author】 WAN Jie-jun;NIE Ben-sui;TENG Ya-ping;ZHENG Xin-hua;LI Li;CHI Lian-xiang;Guangdong Medical College;Department of Endocrinology,Bao’an People’s Hospital of Shenzhen;

【机构】 广东医学院深圳市宝安区人民医院内分泌科

【摘要】 成纤维细胞生长因子21(FGF-21)是近年来新发现的细胞因子之一,内源性FGF-21基因表达水平受过氧化物酶体增生物激活受体(PPAR)α与PPAR-γ的影响。它没有诱导扩散或促进有丝分裂的功能,但有改善胰岛素抵抗、保护胰岛β细胞的存活、改善脂蛋白图谱等生理作用,是改善代谢综合征的独立相关因素,与心血管疾病密切相关。FGF-21可通过酶联免疫吸附测定法检测。在2型糖尿病患者中其水平显著增高,可能是机体的代偿反应,也可能是机体存在FGF-21抵抗。FGF-21被看作是2型糖尿病的一种保护因子,有可能成为新型降糖药物。

【Abstract】 Fibroblast growth factor( FGF-21) is one of the latest discovered cytokines in recent years.The endogenous FGF-21 gene expression level is influenced by PPAR-α and PPAR-γ.It does not function to induce proliferation and promote mitosis.It plays the role of improving insulin resistance,protecting the survival of pancreatic β-cells,improving lipoprotein patterns and so on.It is independently associated with improved metabolic syndrome and closely associated with cardiovascular disease.FGF-21 can be detected by ELISA.Its content is significantly higher in patients with type 2 diabetes,which may be the body’s compensatory response or the resistance of FGF-21.FGF-21 is regarded as a protective factor for type 2 diabetes mellitus which may become a new hypoglycemic agent.

  • 【文献出处】 医学综述 ,Medical Recapitulate , 编辑部邮箱 ,2013年23期
  • 【分类号】R587.1
  • 【被引频次】4
  • 【下载频次】281
节点文献中: 

本文链接的文献网络图示:

本文的引文网络